These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3084115)

  • 21. Radiomimetic activity of phorbol esters exerted in HeLa cells in comparison with their tumor-promoting capacity.
    Kinzel V; Richards J; Marks F; Fürstenberger G
    Cancer Res; 1984 Jan; 44(1):139-43. PubMed ID: 6690031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Agonist- and mitogen-induced desensitization of isoproterenol-stimulated cyclic AMP formation in mouse epidermis in vivo.
    Marks F; Ganss M; Grimm W
    Biochim Biophys Acta; 1981 Nov; 678(1):122-31. PubMed ID: 6118182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced chromosome aberrations in mouse keratinocyte cell lines: a possible genetic mechanism of tumor promotion.
    Dzarlieva-Petrusevska RT; Fusenig NE
    Carcinogenesis; 1985 Oct; 6(10):1447-56. PubMed ID: 4042274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion markers in CD-1 mouse skin by oleandrin.
    Afaq F; Saleem M; Aziz MH; Mukhtar H
    Toxicol Appl Pharmacol; 2004 Mar; 195(3):361-9. PubMed ID: 15020199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anthocyanin- and hydrolyzable tannin-rich pomegranate fruit extract modulates MAPK and NF-kappaB pathways and inhibits skin tumorigenesis in CD-1 mice.
    Afaq F; Saleem M; Krueger CG; Reed JD; Mukhtar H
    Int J Cancer; 2005 Jan; 113(3):423-33. PubMed ID: 15455341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative histomorphometric changes in SENCAR mouse epidermis in response to multiple treatments with complete and stage-specific tumor promoting agents.
    Baxter CS; Andringa A; Chalfin K; Miller ML
    Carcinogenesis; 1989 Oct; 10(10):1855-61. PubMed ID: 2791204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eicosanoids and multistage carcinogenesis in NMRI mouse skin: role of prostaglandins E and F in conversion (first stage of tumor promotion) and promotion (second stage of tumor promotion).
    Fürstenberger G; Gross M; Marks F
    Carcinogenesis; 1989 Jan; 10(1):91-6. PubMed ID: 2910536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low iron diet retards 12-O-tetradecanoyl phorbol-13-acetate-mediated tumor promotion in murine skin.
    Bhasin G; Kauser H; Athar M
    Arch Toxicol; 2004 May; 78(5):283-9. PubMed ID: 14997284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of plant phenols on the expression and activity of phorbol ester-induced PKC in mouse epidermis.
    Szaefer H; Kaczmarek J; Rybczyńska M; Baer-Dubowska W
    Toxicology; 2007 Jan; 230(1):1-10. PubMed ID: 17196728
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation of the arachidonic acid metabolite 8-HETE by extracts of mouse skin treated with phorbol ester in vivo; identification by 1H-n.m.r. and GC-MS spectroscopy.
    Gschwendt M; Fürstenberger G; Kittstein W; Besemfelder E; Hull WE; Hagedorn H; Opferkuch HJ; Marks F
    Carcinogenesis; 1986 Mar; 7(3):449-55. PubMed ID: 3081276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stability of the "second stage" promoter 12-O-retinoylphorbol-13-acetate.
    Tremp GL; Hecker E
    Cancer Res; 1985 May; 45(5):2390-1. PubMed ID: 3986782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of the hydroperoxide response observed in mouse skin treated with tumor promoters in vivo.
    Perchellet EM; Perchellet JP
    Cancer Res; 1989 Nov; 49(22):6193-201. PubMed ID: 2509065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the effect of sn-1,2-didecanoylglycerol and 12-O-tetradecanoylphorbol-13-acetate on cutaneous morphology, inflammation and tumor promotion in CD-1 mice.
    Smart RC; Huang MT; Monteiro-Riviere NA; Wong CQ; Mills KJ; Conney AH
    Carcinogenesis; 1988 Dec; 9(12):2221-6. PubMed ID: 3191568
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alterations in the expression of specific epidermal keratin markers in the hairless mouse by the topical application of the tumor promoters 2,3,7,8-tetrachlorodibenzo-p-dioxin and the phorbol ester 12-O-tetradecanoylphorbol-13-acetate.
    Molloy CJ; Gallo MA; Laskin JD
    Carcinogenesis; 1987 Sep; 8(9):1193-9. PubMed ID: 2441885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Numerical variation of dark cells in normal and chemically induced hyperplastic epidermis with age of animal and efficiency of tumor promoter.
    Klein-Szanto AJ; Slaga TJ
    Cancer Res; 1981 Nov; 41(11 Pt 1):4437-40. PubMed ID: 6796260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Three-stage tumorigenesis in mouse skin: DNA synthesis as a prerequisite for the conversion stage induced by TPA prior to initiation.
    Kinzel V; Fürstenberger G; Loehrke H; Marks F
    Carcinogenesis; 1986 May; 7(5):779-82. PubMed ID: 3084118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurogenic component of phorbol ester-induced mouse skin inflammation.
    Szallasi A; Blumberg PM
    Cancer Res; 1989 Nov; 49(21):6052-7. PubMed ID: 2790819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decrease of epidermal histidase activity by tumor-promoting phorbol esters.
    Colburn NH; Lau S; Head R
    Cancer Res; 1975 Nov; 35(11 Pt 1):3154-9. PubMed ID: 1182705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Macrophage oxidative burst and related cytotoxicity. I. Differential activation by tumor-promoting and non-tumor-promoting phorbol esters.
    Keisari Y; Flescher E; Geva I
    Int J Cancer; 1984 Dec; 34(6):845-8. PubMed ID: 6439653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor induction in initiated mouse skin by phorbol esters and methyl methanesulfonate: correlation between chromosomal damage and conversion ('stage I of tumor promotion') in vivo.
    Fürstenberger G; Schurich B; Kaina B; Petrusevska RT; Fusenig NE; Marks F
    Carcinogenesis; 1989 Apr; 10(4):749-52. PubMed ID: 2495194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.